Omega Therapeutics Inc.
(OMGA)
undefined
undefined%
At close: undefined
0.97
-1.65%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Cash & Equivalents | 68.44M | 70.61M | 186.48M | 22.95M | 2.27M |
Short-Term Investments | 4.99M | 54.06M | 38.84M | - | - |
Long-Term Investments | - | 341.00K | 341.00K | 341.00K | 341.00K |
Other Long-Term Assets | 435.00K | 13.12M | 101.00K | 257.00K | 292.00K |
Receivables | 6.99M | 1.80M | 521.00K | 193.00K | 5.00K |
Inventory | - | 41.15M | -264.00K | - | - |
Other Current Assets | 9.47M | 11.11M | 3.44M | 859.00K | 375.00K |
Total Current Assets | 89.88M | 124.68M | 229.29M | 24.00M | 2.65M |
Property-Plant & Equipment | 114.05M | 7.86M | 3.60M | 3.48M | 2.83M |
Goodwill & Intangibles | - | - | - | - | - |
Total Long-Term Assets | 114.48M | 21.32M | 4.05M | 4.08M | 3.47M |
Total Assets | 204.37M | 146.00M | 233.33M | 28.08M | 6.12M |
Account Payables | 1.62M | 3.11M | 2.11M | 1.06M | 917.00K |
Deferred Revenue | -6.52M | - | - | 3.28M | - |
Short-Term Debt | 26.60M | 6.38M | - | 3.00M | - |
Other Current Liabilities | -1.41M | 12.48M | 9.87M | 3.64M | 1.31M |
Total Current Liabilities | 26.81M | 21.96M | 11.98M | 7.70M | 2.23M |
Long-Term Debt | 113.13M | 17.72M | 19.87M | 8.73M | 11.89M |
Other Long-Term Liabilities | 6.42M | 340.00K | 853.00K | 76.28M | 27.92M |
Total Long-Term Liabilities | 119.54M | 18.06M | 20.72M | 85.01M | 39.81M |
Total Liabilities | 146.35M | 40.03M | 32.70M | 92.71M | 42.04M |
Total Debt | 128.43M | 22.58M | 19.87M | 11.73M | 11.89M |
Common Stock | 55.00K | 48.00K | 48.00K | 5.00K | 5.00K |
Retained Earnings | -334.63M | -237.21M | -134.50M | -66.22M | -36.78M |
Comprehensive Income | -14.00K | -479.00K | -62.00K | -75.22M | -26.71M |
Shareholders Equity | 58.02M | 105.97M | 200.63M | -64.63M | -35.92M |
Total Investments | 4.99M | 54.06M | 38.84M | 341.00K | 341.00K |